Two classes of drugs, porcupine inhibitors and tankyrase inhibitors, affect processes regulating both β-catenin-dependent and β-catenin-independent WNT pathway transduction and thus can interfere with PCP [48,49]. The gene discussed is TNKS; the disease is pneumocystosis.